This interaction activates pro-oncogenic pathways such as TGF-β, Wnt/β-catenin, and MYC, promoting liver fibrosis, immune evasion, and cell proliferation, which collectively advance HCC progression (Yan et al., 2024). This evidence concerns the gene MYC and hepatocellular carcinoma.